Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 10, 2025 17:00 ET | Source: Xilio Therapeutics, Inc. WALTHAM, Mass.,…
Global Leader in Specialty Therapeutics Selects Kneat to Digitize Validation
LIMERICK, Ireland, Jan. 09, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI)…
Relay Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 07, 2025 16:05 ET | Source: Relay Therapeutics, Inc. CAMBRIDGE, Mass.,…
Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases
January 06, 2025 16:30 ET | Source: Generation Bio Co. Novel programs…
Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of Circular RNA
Hamilton, Bermuda, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Further proof of great…
Outlook Therapeutics Reports Financial Results for Fiscal Year 2024 and Provides Corporate Update
December 27, 2024 08:05 ET | Source: Outlook Therapeutics, Inc. LYTENAVA™ is…
Cara Therapeutics Announces Effective Date of 1-for-12 Reverse Stock Split
December 27, 2024 07:00 ET | Source: Cara Therapeutics, Inc. STAMFORD, Conn.,…
Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca
December 24, 2024 09:30 ET | Source: Achilles Therapeutics PLC - Proprietary…
APLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK--(BUSINESS WIRE)--$APLT #APLT--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized…
Basilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera (ceftobiprole) in the United States
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, December 16,…